Analyst consensus rating
Journey Medical Analyst Rating: Strong Buy
DERM is rated Strong Buy by 4 analysts with a $13.75 target. As of 2026-08-23.
Direct answer
Journey Medical's consensus rating is Strong Buy.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $13.75.
Forecast evidence checked August 23, 2026.
Get free Journey Medical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $7.75
- Average price target
- $13.75
- High price target
- $15.00
- Low price target
- $13.00
- Low target gap
- +67.7%
- Target upside
- +77.4%
- High target gap
- +93.5%
- Target range width
- 25.8%
- Consensus rating
- Strong Buy
- Analysts
- 4
- Evidence date
- August 23, 2026
- Valid through
- August 30, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Journey Medical?
Journey Medical has a verified Strong Buy consensus. The same dataset has an average price target of $13.75.
How far are Journey Medical's low and high targets from the recorded price?
The low target implies +67.7%, while the high target implies +93.5%.
How many analysts are included in Journey Medical's consensus?
The verified consensus includes 4 analysts.
How is Journey Medical's target upside or downside calculated?
The average target of $13.75 is divided by the recorded price of $7.75, then one is subtracted to produce +77.4%. This does not guarantee a future return.
When was Journey Medical's analyst forecast verified?
The data was verified on 2026-08-23. The dataset is valid through 2026-08-30.